TGFB1 and glioblastoma: Knockdown of LGALS1 in glioblastoma xenografts, further, led to decreased invasiveness, proliferation, MDSCs, and immunosuppressive macrophages and cytokines (e.g., CCL2 and TGF-β) [160].